Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 1,022 | 801,057 | 8,648 | 3,573 | 3,994 |
| Gross Profit | 1,022 | 801,057 | 8,648 | 3,573 | 3,994 |
| Operating Expenses | 69,578 | 76,547 | 53,292 | 39,577 | 37,160 |
| Operating Income | -68,556 | 724,510 | -44,644 | -36,004 | -33,166 |
| Interest Expense | 1,222 | 1,241 | 1,352 | 1,423 | 1,448 |
| Other Income | 8,375 | 7,198 | 4,442 | 3,113 | 2,781 |
| Pre-tax Income | -61,403 | 730,467 | -41,554 | -34,314 | -31,833 |
| Income Tax | N/A | 110,333 | N/A | N/A | N/A |
| Net Income Continuous | -61,403 | 620,134 | 68,711 | -34,314 | -31,833 |
| Net Income | $-61,403 | $620,134 | $68,711 | $-34,314 | $-31,833 |
| EPS Basic Total Ops | -1.24 | 12.53 | 1.52 | -0.70 | -0.65 |
| EPS Basic Continuous Ops | -1.24 | 12.53 | 1.52 | -0.70 | -0.65 |
| EPS Diluted Total Ops | -1.24 | 12.10 | 1.52 | -0.70 | -0.65 |
| EPS Diluted Continuous Ops | -1.24 | 12.10 | 1.52 | -0.70 | -0.65 |
| EBITDA(a) | $-70,023 | $724,149 | $-44,514 | $-34,724 | $-32,176 |